Long COVID [post-acute sequelae of coronavirus disease 2019]: experimental drugs for cardiopulmonary complications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long COVID [post-acute sequelae of coronavirus disease 2019]: experimental drugs for cardiopulmonary complications

Published:2023-07-03 Issue:7 Volume:32 Page:567-570
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Angeli Fabio¹²,Verdecchia Paolo³⁴,Reboldi Gianpaolo⁵

Affiliation:

1. Department of Medicine and Surgery, University of Insubria, Varese, Italy

2. Department of Medicine and Cardiopulmonary Rehabilitation, Maugeri Care and Research Institute, IRCCS, Tradate, Italy

3. Division of Cardiology, Hospital S. Maria della Misericordia, Perugia, Italy

4. Fondazione Umbra Cuore E Ipertensione-ONLUS, Perugia, Italy

5. Department of Medicine, and Centro di Ricerca Clinica E Traslazionale (CERICLET), University of Perugia, Perugia, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2023.2230121

Reference15 articles.

1. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021

2. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021

3. Lots of long COVID treatment leads, but few are proven

4. Symptoms, complications and management of long COVID: a review

5. Long COVID: major findings, mechanisms and recommendations

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Phenotyping for Curating Research Cohorts of Patients with Post-Acute Sequelae of COVID-19 (PASC) as a Diagnosis of Exclusion;2024-04-15

2. Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infection;European Journal of Internal Medicine;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3